PHARMACYCLICS INC's ticker is PCYC and the CUSIP is 716933106. A total of 256 filers reported holding PHARMACYCLICS INC in Q4 2013. The put-call ratio across all filers is 0.79 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $10,099,000 | +4.1% | 82,600 | 0.0% | 1.10% | -18.6% |
| Q3 2014 | $9,700,000 | +30.9% | 82,600 | 0.0% | 1.35% | +34.3% |
| Q2 2014 | $7,410,000 | -33.6% | 82,600 | -25.9% | 1.01% | -41.8% |
| Q1 2014 | $11,165,000 | +58.5% | 111,400 | +67.3% | 1.73% | -20.1% |
| Q4 2013 | $7,045,000 | – | 66,600 | – | 2.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 9,129,231 | $1,116,140,000 | 11.39% |
| DAFNA Capital Management LLC | 110,928 | $13,562,000 | 10.73% |
| HWG Holdings LP | 107,389 | $13,129,000 | 9.36% |
| Opaleye Management Inc. | 85,000 | $10,392,000 | 5.25% |
| Opus Point Partners Management, LLC | 25,723 | $3,145,000 | 3.11% |
| BB BIOTECH AG | 731,542 | $89,438,000 | 2.90% |
| Peregrine Asset Advisers, Inc. | 33,375 | $4,080,000 | 2.87% |
| HARVEY CAPITAL MANAGEMENT INC | 54,770 | $6,696,000 | 2.57% |
| Parametric Risk Advisors LLC | 300,000 | $36,678,000 | 2.45% |
| BENDER ROBERT & ASSOCIATES | 28,619 | $3,499,000 | 2.29% |